ERBB2 and neoplasm: Finally, in the residual tumour of a TNBC cell line-based MDA-MB-231-derived tumour following si-hVDAC1 treatment, increased levels of prolactin, estrogen and progesterone receptors, as well as Her2, were noted (Figure 6G,H).